WHO ICTRP trial
EUCTR2013-000499-14-FR · ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
EUCTR2013-000499-14-FR · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2013-000499-14-FR |
|---|---|
| Scientific title | N/A - ALLOZITHRO |
| Primary sponsor | ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | France |
| Conditions | MedDRA version: 18.0 Level: LLT Classification code 10049202 Term: Bronchiolitis obliterans System Organ Class: 100000004855 |
| Interventions | Trade Name: AZITHROMYCINE 250 mg Product Name: AZITHROMYCINE 250 mg Pharmaceutical Form: Tablet INN or Proposed INN: AZITHROMYCINE Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 250- Pharmaceutical form… |
| Registration date | Sep 25, 2015 |
| Secondary IDs | P120110 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: